During the Congressional recess in August, GLI prepared for a busy fall. Congress returns in September to advance appropriations bills and debate key legislative priorities.
A Busy Fall of Legislative and Regulatory Activity
read more
Global Liver Institute
Liver Health Policy Updates
GLOBAL LIVER INSTITUTE
Liver Health Policy Updates
GLI Supports NIH Naming Dr. Marrazzo as New Director of the National Institute of Allergy and Infectious Diseases
Global Liver Institute supports the selection of Jeanne M. Marrazzo, M.D., as director of the National Institute of Allergy and Infectious Diseases (NIAID) by the acting director of the NIH. Dr. Marrazzo is currently the director of the Division of Infectious Diseases at the University of Alabama at Birmingham and is a Fellow of the American College of Physicians and of the Infectious Diseases Society of America.
GLI Leads Charge for Common-Sense Policies to Advance High Quality Care for Everyone
In July, GLI used its voice to challenge policymakers to take steps to advance high quality, equitable care for everyone.
GLI and Others Nominate Julius M. Wilder MD, PhD to National Diabetes and Digestive and Kidney Diseases Advisory Council (NDDKAC)
Global Liver Institute is pleased to nominate Julius M. Wilder MD, PhD to be a member of the NIDDK’s National Diabetes and Digestive and Kidney Diseases Advisory Council (NDDKAC).
GLI Urges Passage of the Treat and Reduce Obesity Act (TROA)
Global Liver Institute recognizes the relationship between nonalcoholic fatty liver disease (NAFLD), its advanced form, nonalcoholic steatohepatitis (NASH), and obesity. Preventing liver disease is directly associated with treating and reducing obesity. Worldwide, NASH affects more than 148 million people and continues to become more prevalent each year.
GLI Leads Bipartisan Access to Innovation Strategy Across HHS, Congress, and the White House
We have so much more to do to support liver health and appreciate your consistent engagement and support in those efforts!
GLI provided comments to FDA on the importance of patient preference information (PPI)
Well-designed and well-conducted PPI studies elicit which attributes are important to patients, how important they are, and what trade-offs patients are willing to make.
GLI Continues to Advocate for Liver Patients with the Biden Administration, Congress and Federal Agencies
While a divided Congress and the upcoming Presidential campaign year make for challenging times for policymakers, Global Liver Institute is committed to advocating for liver patients at all levels of regulatory and legislative decision making.
Support Legislation to Protect Living Organ Donors
Global Liver Institute is proud to support H.R. 2544, the Securing the U.S. Organ Procurement and Transplantation Network Act. This bipartisan legislation responds to the urgent need for reforming the Organ Procurement Transplantation Network (OTPN), breaking up the national monopoly contract so that the Health Resources Services Administration (HRSA) can run an open, competitive process and choose from the best of the best in each field (e.g., health policy, IT, logistics, patient safety) to save more lives.
Global Liver Institute Frustrated by FDA GIDAC Committee Failure to Recognize Serious, Unmet Need of Liver Patients in Rejection of Obeticholic Acid for Pre-Cirrhotic Fibrosis Due to NASH
Despite acknowledging OCA met the endpoint established by the FDA of reducing fibrosis by at least one stage, GIDAC voted against approval for treatment for NASH.
GLI Calls for Passage of the Organ Procurement and Transplantation Act
Global Liver Institute is proud to support H.R. 2544, the Securing the U.S. Organ Procurement and Transplantation Network Act. This bipartisan legislation responds to the urgent need for reforming the Organ Procurement Transplantation Network (OTPN), breaking up the national monopoly contract so that the Health Resources Services Administration (HRSA) can run an open, competitive process and choose from the best of the best in each field (e.g., health policy, IT, logistics, patient safety) to save more lives.
Global Liver Institute Applauds Dr. Monica Bertagnolli’s Nomination as Director of the National Institutes of Health
Global Liver Institute proudly supports President Biden’s nomination of Monica Bertagnolli, MD, to be the Director of the National Institutes of Health (NIH).